Selected Presentations & Appearances
Interesting and Novel Complex Medical Dermatology Cases
- North Carolina Dermatology Association Annual Meeting
· January 25, 2020
Invited Talk
North Carolina Dermatology Association,
The future of systemic and cutaneous lupus erythematosus treatment: targeting type I interferons and plasmacytoid dendritic cells
- North Carolina Dermatology Association Annual Meeting
· January 24, 2020
Invited Talk
North Carolina Dermatology Association,
Targeting Plasmacytoid Dendritic Cells: A Promising Therapeutic Pathway in Systemic and Cutaneous Lupus Erythematosus
- Duke Pinnell Symposium
· November 1, 2019
Invited Talk
Duke Dermatology,
Searle Center
Dermatology side effects of novel oncology therapies
- Senior Talk
· May 2018
Lecture
Duke Dermatology,
Duke Dermatology
NIH Dermatology Grand Rounds
· March 2017
Lecture
National Instituate of Health,
National Instituate of Health
Subacute Cutaneous Lupus Erythematosus Associated with Anti-Programmed Cell Death (PD)-1 Therapy
- Poster Presentation
· March 2017
National Scientific Meeting
Medical Dermatology Society Meeting,
San Diego Convention Center
Scleromyxedema Complicated by the Dermato-Neuro Syndrome Successfully Treated with IVIG and Steroids
- Resident Presentations
· January 2016
National Scientific Meeting
North Carolina Dermatology Asssociation,
Pinehurst Country Club
Caspase 3 Promotes Surviving Tumor Cell Growth After Radiation and Vemurafenib Therapy
- Duke University School of Medicine AOA Day
· August 2013
Invited Talk
Duke University School of Medicine,
Duke University School of Medicine
Apoptosis and Caspase 3 Stimulate Melanoma Tumor Repopulation During Vemurafenib and PD0325901 Therapy
- International Investigative Dermatology Meeting
· May 2013
International Meeting or Conference
International Investigative Dermatology,
Edinburgh, Scotland
Apoptosis and Caspase 3 Stimulate Melanoma Tumor Repopulation During Vemurafenib Therapy
- Howard Hughes Medical Institute Medical Fellows Program Meeting
· May 2013
National Scientific Meeting
Howard Hughes Medical Institute ,
Bethesda, MD
Breast Cancer Risk and Progestin Dosage: Low-dose progestins induce the expression of genes and proteins that regulate the cell cycle in breast cancer cells
- Duke University
· May 2010
Other
Duke University,
Service to the Profession
Skin Cancer Screener
·
2018
- 2018
Event Attendance
TROSA,
Skin Cancer Screener
·
2018
- 2018
Event Attendance
NCCU,
Academic & Administrative Activities
Clinical Competency Commityee, Duke Dermatology Residency Program
NC Rheumatology Dermatology Meeting Co-Founder
Clinical Activities
I have 6 (1/2 day) general dermatology clinics at South Durham (Southpoint location) and 1 (1/2 day) autoimmune specialty dermatology clinic at Duke Clinic 3K (Duke South/Hospital location)